Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial platform. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The commercial platform includes a prescription drugs business and a consumer health business for over-the-counter drugs.
| Last: | $14 |
|---|---|
| Change Percent: | -1.06% |
| Open: | $14.12 |
| Close: | $14.15 |
| High: | $14.12 |
| Low: | $14 |
| Volume: | 1,812 |
| Last Trade Date Time: | 03/13/2026 11:57:21 am |
| Market Cap: | $2,607,787,313 |
|---|---|
| Float: | 104,485,926 |
| Insiders Ownership: | 2.8% |
| Institutions: | 28 |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | https://www.hutch-med.com |
| Country: | HK |
| City: | Hong Kong |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about HUTCHMED (China) Limited (NASDAQ: HCM).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
